SEARCH

SEARCH BY CITATION

References

  • 1
    Chazouilleres O, Mamish D, Kim M, Carey K, Ferrell L, Roberts JP, et al. “Occult” hepatitis B virus as source of infection in liver transplant recipients. Lancet 1994; 343:142146. MEDLINE
  • 2
    Roche B, Samuel D, Gigou M, Feray C, Virot V, Schmets L, et al. De novo and apparent de novo hepatitis B virus infection after liver transplantation. J Hepatol 1997; 26:517526. MEDLINE
  • 3
    Douglas DD, Rakela J, Wright TL, Krom RA, Wiesner RH. The clinical course of transplantation-associated de novo hepatitis B infection in the liver transplant recipient. Liver Transpl Surg 1997; 3:105111. MEDLINE
    Direct Link:
  • 4
    Wachs ME, Amend WJ, Ascher NL, Bretan PN, Emond J, Lake JR, et al. The risk of transmission of hepatitis B from HBsAg(−), HBcAb(+), HBIgM(−) organ donors. Transplantation 1995; 59:230234. MEDLINE
  • 5
    Dodson SF, Issa S, Araya V, Gayowski T, Pinna A, Eghtesad B, et al. Infectivity of hepatic allografts with antibodies to hepatitis B virus. Transplantation 1997; 64:15821584. MEDLINE
  • 6
    Dickson RC, Everhart JE, Lake JR, Wei Y, Seaberg EC, Wiesner RH, et al. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Gastroenterology 1997; 113:16681674. MEDLINE
  • 7
    Suarez A, Viejo G, Navascues CA, Garcia R, Diaz G, Saro C, et al. The prevalence of hepatitis A, B and C viral markers in the population of Gijon between 26 and 65 years old. Gastroenterol Hepatol 1997; 20:347352. MEDLINE
  • 8
    Salleras L, Bruguera M, Vidal J, Taberner JL, Plans P, Bayas JM, et al. Prevalence of hepatitis B markers in the population of Catalonia (Spain). Rationale for universal vaccination of adolescents. Eur J Epidemiol 1992; 8:640644. MEDLINE
  • 9
    Baker B, Di Bisceglie AM, Kaneko S, Miller R, Einstone S, Waggoner JG, et al. Determination of hepatitis B virus DNA in serum using the polymerase chain reaction: Significance and correlation with serological and biochemical markers. Hepatology 1991; 13:632636. MEDLINE
  • 10
    Prieto M, Berenguer M, Rayon JM, Cordoba J, Arguello L, Carrasco D, et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: Relationship with rejection episodes. Hepatology 1999; 29:250256. MEDLINE
  • 11
    Uemoto S, Sugiyama K, Marusawa H, Inomata Y, Asonuma K, Egawa H, et al. Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants. Transplantation 1998; 65:494499. MEDLINE
  • 12
    Crespo J, Fabrega E, Casafont F, Rivero M, de las Heras G, de la Peña J, et al. Severe clinical course of de novo hepatitis B infection after liver transplantation. Liver Transpl Surg 1999; 5:175183. MEDLINE
  • 13
    Prieto M, Córdoba J, Rayóon JM, García-Herola A, Berenguer M, Carrasco D, et al. Good response to lamivudine therapy in patients with de novo hepatitis B following orthotopic liver transplantation: A pilot study [abstract]. Hepatology 1998; 28:348A.
  • 14
    Perrillo R, Rakela J, Dienstag J, Levy G, Martin P, Wright T, et al. Multicenter study of lamivudine therapy for hepatitis B after liver transplantation. Lamivudine Transplant Group. Hepatology 1999; 29:15811586. MEDLINE